4 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 2 | Terminated 2 |
Follow veledimex: new trials by email Literature Review of veledimex trials Research Report on veledimex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea) FCX-013, veledimex - Morphea, Scleroderma, Localized | Phase 1 / Phase 2 | Terminated | Castle Creek Biosciences, LLC. | 1 | 2019-12-18 | 2024-01-23 |
| Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc - Glioblastoma | Phase 2 | Terminated | Alaunos Therapeutics | 40 | 2019-08-01 | 2025-04-18 |
| A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer Ad-RTS-hIL-12, Veledimex - Metastatic Breast Cancer | Phase 1 / Phase 2 | Terminated | Alaunos Therapeutics | 9 | 2015-07-18 | 2025-08-28 |
| Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. Ad-RTS-hIL-12 and Veledimex, Palifosfamide - Breast Cancer Nos Metastatic Recurrent | Phase 2 | Terminated | Alaunos Therapeutics | 12 | 2013-04-04 | 2025-08-28 |
Breast Neoplasms (2) · Glioblastoma (1) · Scleroderma, Diffuse (1) · Scleroderma, Localized (1)
Alaunos Therapeutics (3) · Castle Creek Biosciences, LLC. (1)
United States (4)
Jaymes Holland (3)